CEO SUMMARY: Even as public lab and anatomic pathology companies enjoy sustained growth in specimen volumes and revenues, fundamental shifts in the basic marketplace have changed the competitive environment. Surprisingly, the most open market segment is anatomic pathology specimens referred by physicians’ offices. Hospital inpatient and outpatient testing continues to be a limited growth opportunity […]
To access this post, you must purchase The Dark Report.